Generic drugs = Lucrative Whistle blowing
Discussion
I am involved in the pharmaceutical industry and some of the practices I see going on are unbelievable. The FDA police the industry in the US and have powers beyond the US borders. But, some just do not learn and will carry on inventing results to make sales.
The generics are particularly bad because they are on tight timelines and budgets. For those that do not know a generic drug manufacturer copies the active ingredient of the original once the patent has lapsed. The first through the door gets a period of time when they are the only generic to be allowed to sell the drug. So time is key. We had a company in the US that took the OEM drug and put their label over the bottle to submit to the FDA. The label fell off.
Ranbaxy is a huge generic that also forms part of the production of many OEM drugs in partnerships with the OEM. Ranbaxy drugs can not be sold through the NHS but the OEM drugs they work on can. In 2013 Ranbaxy were fined $500 for falsification of data. I am sure they consider these fines operating costs.
Anyway, to the point, the whistle blowers now get paid 10% of the fines. A former worker walked away with nearly $50 million for alerting the FDA.
Generic Drug Maker Pleads Guilty
The generics are particularly bad because they are on tight timelines and budgets. For those that do not know a generic drug manufacturer copies the active ingredient of the original once the patent has lapsed. The first through the door gets a period of time when they are the only generic to be allowed to sell the drug. So time is key. We had a company in the US that took the OEM drug and put their label over the bottle to submit to the FDA. The label fell off.
Ranbaxy is a huge generic that also forms part of the production of many OEM drugs in partnerships with the OEM. Ranbaxy drugs can not be sold through the NHS but the OEM drugs they work on can. In 2013 Ranbaxy were fined $500 for falsification of data. I am sure they consider these fines operating costs.
Anyway, to the point, the whistle blowers now get paid 10% of the fines. A former worker walked away with nearly $50 million for alerting the FDA.
Generic Drug Maker Pleads Guilty
The regulatory barriers to getting a novel product approved are so massive I believe we're going to see a lot of this over the next few years.
I've spent much of my career developing combination products (drug in a delivery device). When I discuss the challenges with engineers/scientists, even from other regulated industries, they are amazed at the level of evidence required to demonstrate performance. It's a massively time consuming and expensive process.
Many of the generics manufacturers have nowhere near the competence needed to produce equivalent products. I'm a member of some Linkedin groups where questions are often raised by staff from Indian generics companies; some of those questions are unbelievably naive. I'm not criticising the staff, if you haven't worked through the pain of getting a product approved by the FDA then you just won't know.
Sadly, the way the regulatory process is structured there is little incentive in developing new or improved products unless they will be massive blockbusters.
I've spent much of my career developing combination products (drug in a delivery device). When I discuss the challenges with engineers/scientists, even from other regulated industries, they are amazed at the level of evidence required to demonstrate performance. It's a massively time consuming and expensive process.
Many of the generics manufacturers have nowhere near the competence needed to produce equivalent products. I'm a member of some Linkedin groups where questions are often raised by staff from Indian generics companies; some of those questions are unbelievably naive. I'm not criticising the staff, if you haven't worked through the pain of getting a product approved by the FDA then you just won't know.
Sadly, the way the regulatory process is structured there is little incentive in developing new or improved products unless they will be massive blockbusters.
Another generic I worked with years ago got shut down for falsifying data. This was because of a Whistle blower again. In this case the whistle blower went in to his manager's office with failing QC data and was told that if he didn't find a way of making the data pass he would be replaced. Apparently standard practice. I have involvement in validation and qualification of methods and instruments for testing. You can write as many SOPs as you want but if a corrupt scientists wants a pass they can make one. In my role we deal with the FDA, FBI and IRS both directly and indirectly. It seams to me that some companies will continue to put people's lives at risk because there is a fortune to be made.
I always take a look at the origin of my family's medication and there is a long list of companies that are on my banned list. There is no way I trust them.
I always take a look at the origin of my family's medication and there is a long list of companies that are on my banned list. There is no way I trust them.
Interesting stuff.
Got to wonder about the number of Chinese fakes in the system, too: http://www.bbc.co.uk/news/uk-england-beds-bucks-he... I know that I've definitely had one batch of medication that seemed way less effective than the others.
Got to wonder about the number of Chinese fakes in the system, too: http://www.bbc.co.uk/news/uk-england-beds-bucks-he... I know that I've definitely had one batch of medication that seemed way less effective than the others.
NWTony said:
In fairness the innovative drug manufacturers are hardly whiter than white.
h0b0 said:
Another generic I worked with years ago got shut down for falsifying data. This was because of a Whistle blower again. In this case the whistle blower went in to his manager's office with failing QC data and was told that if he didn't find a way of making the data pass he would be replaced. Apparently standard practice.
I'd agree with NWTony that those practices aren't limited to generic manufacturers. In the past, I've seen examples of "creative" ways to pass products. Not helped when some of the industry standard tests are rather more variable than ideal. Certainly not standard practice in very recent years though.
Rubin215 said:
Me mate Dave got dun wiv a big box of pharmasuiticals.
Most of his rattle was mitsubishis and smileys but I'm top dollar he would have had some of them generics in there alsos.
He deals to lots of rozzers anyway so only got six months.
Innit...
I do miss the very dark tints on company cars from my pharma days Most of his rattle was mitsubishis and smileys but I'm top dollar he would have had some of them generics in there alsos.
He deals to lots of rozzers anyway so only got six months.
Innit...

I work in the pharma industry in the Development side and i don't see how issues like the ones stated can get through... Yes you can attempt to fudge the results but if all of the validation criteria, SOP's, methods, etc are clearly defined then any deviations will be easy to identify I.e if you change the test methods, etc. If you are just putting forward random results then the company should have their licensed revoked as that is shocking behaviour...
Google Ranbaxy and consent decree.
I'm sure most people have never heard of Ranbaxy but they are a huge generic. Just like all the other faceless generics.
As has been said before though it's not just the generics at it. Look through J&J's recent history.
All SOPs rely on the chemist putting in the correct sample. They don't. On top of that you assume the SOPs are accurate. I was involved with a clinical account last year that ran samples through a column the wrong way. Their SOP had said connect it that way but their column manager was configured the other way round. Another example at another clinical company. They hadn't understood the numbering pattern of their samples and put the samples in the wrong order.
My favorite example was the company that was testing sample following their SOP. Hit button and if you see "pass" sign it off. We were consulting on their batch issues and found out that the test button was the battery test button.
Finally, don't forget vindictive employees. I have know of a human crap in the middle of manufacturing. Blue tablets that should have been white due to someone dropping a pen into the batch. And finally, the chemist caught on video taking a piss into the solvents.
I'm sure most people have never heard of Ranbaxy but they are a huge generic. Just like all the other faceless generics.
As has been said before though it's not just the generics at it. Look through J&J's recent history.
All SOPs rely on the chemist putting in the correct sample. They don't. On top of that you assume the SOPs are accurate. I was involved with a clinical account last year that ran samples through a column the wrong way. Their SOP had said connect it that way but their column manager was configured the other way round. Another example at another clinical company. They hadn't understood the numbering pattern of their samples and put the samples in the wrong order.
My favorite example was the company that was testing sample following their SOP. Hit button and if you see "pass" sign it off. We were consulting on their batch issues and found out that the test button was the battery test button.
Finally, don't forget vindictive employees. I have know of a human crap in the middle of manufacturing. Blue tablets that should have been white due to someone dropping a pen into the batch. And finally, the chemist caught on video taking a piss into the solvents.
Rovinghawk said:
h0b0 said:
The FDA police the industry in the US and have powers beyond the US borders.
Where did they get powers to police stuff in foreign countries?streaky said:
h0b0 said:
In 2013 Ranbaxy were fined $500 for falsification of data. I am sure they consider these fines operating costs.
I'd consider $500 "operating costs". It's less than a weekly Travelcard for me.Streaky
Now $500m would be an impressive weekly travelcard!
Yes, I missed the M. It's $500,000,000. That's a decent amount of money. J$J were fined $2,000,000,000.
The FDA do not have legal powers in other countries. But, if you want to sell in the US you have to allow them access to any facility in the world. Officially they have to give notice but there's a loop hole. They can audit your US facility with no notice and then they count that as being served notice for all your facilities around the world.
The other power they have is an agreement with the European equivalent that if the FDA reject a drug the Europeans will automatically reject it as well. So, they are almost an international body. Even the Chinese are bowing to the FDAs power.
The FDA do not have legal powers in other countries. But, if you want to sell in the US you have to allow them access to any facility in the world. Officially they have to give notice but there's a loop hole. They can audit your US facility with no notice and then they count that as being served notice for all your facilities around the world.
The other power they have is an agreement with the European equivalent that if the FDA reject a drug the Europeans will automatically reject it as well. So, they are almost an international body. Even the Chinese are bowing to the FDAs power.
h0b0 said:
The generics are particularly bad because they are on tight timelines and budgets. For those that do not know a generic drug manufacturer copies the active ingredient of the original once the patent has lapsed. The first through the door gets a period of time when they are the only generic to be allowed to sell the drug. So time is key. We had a company in the US that took the OEM drug and put their label over the bottle to submit to the FDA. The label fell off.
Like a mini patent? What is the purpose of that?h0b0 said:
Yes, I missed the M. It's $500,000,000. That's a decent amount of money. J$J were fined $2,000,000,000.
The FDA do not have legal powers in other countries. But, if you want to sell in the US you have to allow them access to any facility in the world. Officially they have to give notice but there's a loop hole. They can audit your US facility with no notice and then they count that as being served notice for all your facilities around the world.
The other power they have is an agreement with the European equivalent that if the FDA reject a drug the Europeans will automatically reject it as well. So, they are almost an international body. Even the Chinese are bowing to the FDAs power.
largely agree but to clarify, other regulatory bodies approve drugs independently, you can have approval in the EU but not in the US and vice versa. Some drugs are banned int he EU but permitted in the US for instance.The FDA do not have legal powers in other countries. But, if you want to sell in the US you have to allow them access to any facility in the world. Officially they have to give notice but there's a loop hole. They can audit your US facility with no notice and then they count that as being served notice for all your facilities around the world.
The other power they have is an agreement with the European equivalent that if the FDA reject a drug the Europeans will automatically reject it as well. So, they are almost an international body. Even the Chinese are bowing to the FDAs power.
The Chinese bow to no-one, they are literally a law unto themselves, procedures and limits and properties agreed worldwide hold no sway in China, they often demand things that favour local producers over foreign competitors without scientific rationale. China is a huge and growing market so drug manufacturers are very keen to get a foothold, regardless of cost.
I have a little Chinese knowledge and the market for testing food and herbal products to be sold on the US is massive. The US laws now make it impossible for the Chinese to ignore them. It has changed the market dramatically over the last couple of years. Business is driving this not the Chinese government.
And, you are right to say it is possible to have drugs approved in one geography and not the other. But, if you have approval in one and are seeking approval in another the process is normally a formality. To be approved in one and not the other is a big deal and the agencies get pissed off with each other when it happens.
And, you are right to say it is possible to have drugs approved in one geography and not the other. But, if you have approval in one and are seeking approval in another the process is normally a formality. To be approved in one and not the other is a big deal and the agencies get pissed off with each other when it happens.
Gassing Station | Speed, Plod & the Law | Top of Page | What's New | My Stuff


